{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:49:40Z","timestamp":1791409780218,"version":"4.3.3"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110422","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:07:54Z","timestamp":1787238474000},"page":"110422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, anticancer evaluation, and molecular dynamics-based computational investigation of novel pyrimidine-benzothiazole\/phenyl hybrid-based VEGFR-2-targeted derivatives with antioxidant, DNA nicking, DNA interaction, and cytotoxicity studies"],"prefix":"10.1016","volume":"181","author":[{"given":"Karan A.","family":"Kamle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyansh R.","family":"Mevada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena H.","family":"Hirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Vanshiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishith","family":"Gamit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi K.","family":"Barad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigam","family":"Bhanugariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muskan","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Thakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurang","family":"Shindhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanu","family":"Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Vasava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandan","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip V.","family":"Vasava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110422_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110422_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.694","article-title":"Mechanisms of resistance to tyrosine kinase inhibitor-targeted therapy and overcoming strategies","volume":"5","author":"Ou","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.bioorg.2026.110422_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10238-007-0145-8","article-title":"Uncovering Pandora\u2019s vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib","volume":"7","author":"Porta","year":"2007","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bioorg.2026.110422_bb0020","article-title":"Acquired resistance to tyrosine kinase targeted therapy: mechanism and tackling strategies","volume":"209","author":"Wu","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2026.110422_bb0025","doi-asserted-by":"crossref","first-page":"32985","DOI":"10.1039\/D4RA05244G","article-title":"Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents","volume":"14","author":"Chaudhari","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110422_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14534","article-title":"Structural and molecular insights from dual inhibitors of EGFR and VEGFR2 as a strategy to improve the efficacy of Cancer therapy","volume":"103","author":"Budipramana","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2026.110422_bb0035","doi-asserted-by":"crossref","first-page":"12184","DOI":"10.1039\/D3RA00416C","article-title":"Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2: design, synthesis, biological evaluations, and in silico studies","volume":"13","author":"Al-Muntaser","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110422_bb0040","first-page":"2742","article-title":"New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study","volume":"13","author":"Mohamed","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110422_bb0045","first-page":"5397","article-title":"Discovery of novel potent VEGFR-2 inhibitors exerting significant antiproliferative activity against Cancer cell lines","volume":"61","author":"Fallica","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110422_bb0050","article-title":"Hybrid drugs\u2014a strategy for overcoming anticancer drug resistance?","volume":"22","author":"Kubiszewski-Jakubiak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110422_bb0055","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/ph15091071","article-title":"Concept of hybrid drugs and recent advancements in anticancer hybrids","volume":"15","author":"Borah","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110422_bb0060","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1021\/acs.jcim.1c01554","article-title":"Discovery of anticancer hybrid molecules by supervised machine learning models and in vitro validation in drug-resistant chronic myeloid Leukemia cells","volume":"62","author":"Bhatt","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110422_bb0065","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.3390\/ijms23158117","article-title":"An overview of the biological evaluation of selected nitrogen-containing heterocycle medicinal chemistry compounds","volume":"23","author":"Ibraheem","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110422_bb0070","first-page":"4120","article-title":"Design, synthesis, and mechanistic anticancer evaluation of new pyrimidine-tethered compounds","volume":"10","author":"Mosa","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110422_bb0075","first-page":"14295","article-title":"Identification of pyrimidine-based Lead compounds for understudied kinases implicated in driving neurodegeneration","volume":"64","author":"Taber","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110422_bb0080","first-page":"2830","article-title":"Exploration of type II binding mode: a privileged approach for kinase inhibitor focused drug discovery?","volume":"13","author":"Liao","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110422_bb0085","first-page":"280","article-title":"Furan- and Furopyrimidine-based derivatives: synthesis, VEGFR-2 inhibition, and in vitro cytotoxicity","volume":"16","author":"Ibrahim","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110422_bb0090","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/acsmedchemlett.4c00095","article-title":"Insight on some newly synthesized trisubstituted Imidazolinones as VEGFR-2 inhibitors","volume":"15","author":"Hameed","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110422_bb0095","first-page":"21480","article-title":"Synthetic strategies towards benzothiazole-based compounds of therapeutic potency: experimental, investigational and approved drugs","volume":"15","author":"Rahman","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110422_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1384301","article-title":"Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticancer and Antiinflammatory agents","volume":"12","author":"Xu","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2026.110422_bb0105","first-page":"20432","article-title":"Novel 2-Aminobenzothiazole derivatives: docking, synthesis, and biological evaluation as anticancer agents","volume":"9","author":"Odugbemi","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110422_bb0110","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1039\/D2MD00431C","article-title":"Development of thiazole-appended novel hydrazones as a new class of alpha-amylase inhibitors with anticancer assets: an in silico and in vitro approach","volume":"14","author":"Chahal","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110422_bb0115","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3390\/ph16081162","article-title":"Chemistry and pharmacology of fluorinated drugs approved by the FDA (2016-2022)","volume":"16","author":"Ogawa","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110422_bb0120","first-page":"1895","article-title":"Metabolic stability of fluorinated small molecules: a physical organic chemistry perspective","volume":"69","author":"Gillis","year":"2026","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110422_bb0125","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2166036","article-title":"New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study","volume":"38","author":"Al-Sanea","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110422_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29133186","article-title":"Identification of benzothiazoles bearing 1, 3, 4-thiadiazole as antiproliferative hybrids targeting VEGFR-2 and BRAF kinase: design, synthesis, BIO evaluation and in silico study","volume":"29","author":"Ewes","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110422_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109066","article-title":"Design, synthesis, and computational validation of novel benzothiazole derivatives as dual anticancer-antioxidant agents targeting VEGFR-2","author":"Mohamed","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110422_bb0140","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.5c10972","article-title":"Structure-guided design of benzothiazole and benzimidazole-based urea derivatives curtailing oncogenic signaling via concurrent inhibition of VEGFR-2, EGFR, and c-Met","author":"Shaheen","year":"2026","journal-title":"ACS Omega"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110422_bb0145","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1039\/D5MD00787A","article-title":"Novel chalcone 2-thiopyrimidine conjugates as dual VEGFR-2\/BRAF inhibitors: design, synthesis, in vitro cytotoxicity, and molecular docking study","volume":"16","author":"Abdelaziz","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110422_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109608","article-title":"Synthesis of 4-chloro-N\u2032-(2-cyanoacetyl) benzohydrazide derivatives, cytotoxicity, VEGFR-2\/EGFRT790M bioassays and in silico docking\/ADMET studies","author":"Deghaidi","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110422_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118679","article-title":"Design and synthesis of pyrazolopyrimidinone derivatives as dual VEGFR\/Aurora kinase inhibitors against hepatocellular and breast carcinomas","volume":"192","author":"Anwer","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110422_bb0160","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/17568919.2025.2453409","article-title":"Dual VEGFR-2 and EGFRT790M inhibitors of phenyldiazenes: anticancer evaluations, ADMET, docking, design and synthesis","volume":"17","author":"Alsulaimany","year":"2025","journal-title":"Future Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110422_bb0165","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1039\/D5RA00166H","article-title":"Design, nanogel synthesis, anti-proliferative activity and in silico ADMET profile of pyrazoles and pyrimidines as topo-II inhibitors and DNA intercalators","volume":"15","author":"Aljohani","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110422_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108746","article-title":"ADMET, docking, anticancer evaluations, design and synthesis of pyrazolo [1, 5-a] pyrimidines substituted with furan and phenyldiazene as dual EGFRT790M and VEGFR-2 inhibitors","author":"Alsulaimany","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110422_bb0175","article-title":"In vitro cytotoxicity in A549, Hepg2, MCF-7, and DLD-1 cancer cell lines and ADME\/toxin analysis of a benzimidazole derivative","volume":"37","author":"Bilici","year":"2025","journal-title":"J. King Saud Univ. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110422_bb0180","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/17568919.2025.2517533","article-title":"Pyrimidine hybrids with in vivo anticancer therapeutic potential","volume":"17","author":"Liu","year":"2025","journal-title":"Future Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110422_bb0185","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/RPS.RPS_222_25","article-title":"New 5-(pyridin-3-yl)-1, 3, 4-oxadiazoles derivatives as VEGFR2 inhibitors: in silico study, synthesis, and cytotoxicity evaluation","volume":"21","author":"Abdulhussein","year":"2026","journal-title":"Res. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110422_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/cssc.202402383","article-title":"Guidelines for evaluating the antioxidant activity of lignin via the 2, 2-diphenyl-1-picrylhydrazyl (DPPH) assay","volume":"18","author":"Diment","year":"2025","journal-title":"ChemSusChem"},{"key":"10.1016\/j.bioorg.2026.110422_bb0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s43088-022-00297-x","article-title":"Green synthesis of silver nanoparticles using dietary antioxidant rutin and its biological contour","volume":"11","author":"Kubavat","year":"2022","journal-title":"Beni-Suef Univ. J. Basic Appl. Sci."},{"key":"10.1016\/j.bioorg.2026.110422_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.126966","article-title":"Sustainable biosynthesis of silver nanoparticles from Gmelina arborea: photocatalytic, in vitro biological implications, and in silico analysis for microbial metalloproteins","volume":"422","author":"Thakar","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2026.110422_bb0205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s43141-023-00525-6","article-title":"Gold nanoparticles synthesis using Gymnosporia Montana L. and its biological profile: a pioneer report","volume":"21","author":"Patel","year":"2023","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.bioorg.2026.110422_bb0210","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41598-024-51443-7","article-title":"In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2","volume":"14","author":"Hashem","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110422_bb0215","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1021\/acsomega.4c08885","article-title":"Novel benzimidazole-oxadiazole derivatives as anticancer agents with VEGFR2 inhibitory activity: design, synthesis, in vitro anticancer evaluation, and in silico studies","volume":"10","author":"\u00c7evik","year":"2025","journal-title":"ACS Omega"},{"issue":"28","key":"10.1016\/j.bioorg.2026.110422_bb0220","doi-asserted-by":"crossref","first-page":"26099","DOI":"10.1039\/D6RA01925K","article-title":"Design, synthesis, antimicrobial and antioxidant evaluation, cytotoxicity assessment, and molecular dynamics-based computational studies of novel PABA analogues as dual DHPS\/DHFR inhibitors","volume":"16","author":"Devliya","year":"2026","journal-title":"RSC Adv."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110422_bb0225","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1021\/acsomega.4c08149","article-title":"Esterified indole-3-propionic acid: a novel inhibitor against cholinesterase identified through experimental and computational approaches","volume":"10","author":"Sidhambaram","year":"2025","journal-title":"ACS Omega"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:56:35Z","timestamp":1791406595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S0045206826009582"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110422","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, anticancer evaluation, and molecular dynamics-based computational investigation of novel pyrimidine-benzothiazole\/phenyl hybrid-based VEGFR-2-targeted derivatives with antioxidant, DNA nicking, DNA interaction, and cytotoxicity studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110422"}}